Literature DB >> 11424125

HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease.

E Sagnelli1, N Coppola, C Scolastico, A R Mogavero, P Filippini, F Piccinino.   

Abstract

To evaluate whether HCV genotype and a "silent" HBV infection may be related to a more severe clinical presentation of liver disease, 205 anti-HCV/HCV-RNA positive, HBsAg/anti-HBs negative patients with chronic hepatitis (113 males and 92 females; median age 55 years, range 18-77), were studied on presentation at the Liver Unit from January 1993 to December 1997. Presence of serum anti-HBc, in the absence of HBsAg and anti-HBs, was considered a marker of "silent" HBV infection. Of the 205 patients, 134 had undergone percutaneous liver biopsy. Two main diagnosis groups were established: the mild liver disease group (76 patients), and the severe liver disease group (109 patients); 20 patients who had refused to undergo liver biopsy were not included in the clinical and virological evaluation because the diagnosis was uncertain. The prevalence of severe liver disease was similar in the genotype 1 and non-1 groups (61.3% of 98 patients with genotype 1 and 52.9% of 70 patients with a non-1 genotype). Instead, the 88 patients with "silent" HBV infection showed a higher percentage of severe liver disease than the 97 anti-HBc negative patients (72.7% vs. 46.4%, respectively: P < 0.0005). Of the 88 anti-HBc positive patients, the prevalence of those with severe liver disease was similar in the 32 cases with serum HBV-DNA as detected by PCR and in the 56 HBV-DNA negative (81.2% vs. 67.8%, P = 0.4). The relation between "silent" HBV infection and severe liver disease was observed both in genotype 1 and non-1 infected patients. Nevertheless, the anti-HBc negative patients infected by genotype 1 showed a severe liver disease more frequently than those infected by a non-1 genotype, with a difference that is significant to the statistical analysis (P < 0.05). The findings suggest that "silent" HBV infection in anti-HCV positive chronic hepatitis enhances the severity of the liver disease. Evidence was also found that in patients without "silent" HBV infection there is a correlation between the presence of HCV genotype 1 and the severity of liver disease. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11424125     DOI: 10.1002/jmv.1057

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  29 in total

1.  Identification of acute vaccine-preventable hepatitis in individuals with chronic hepatitis in British Columbia between 1991 and 2007.

Authors:  Lily Fang; Amanda Yu; Jane A Buxton
Journal:  Can J Infect Dis Med Microbiol       Date:  2011       Impact factor: 2.471

Review 2.  Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals.

Authors:  Nicola Coppola; Mariantonietta Pisaturo; Rosa Zampino; Margherita Macera; Caterina Sagnelli; Evangelista Sagnelli
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

Review 3.  Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy.

Authors:  Mindie H Nguyen; Grace Wong; Edward Gane; Jia-Horng Kao; Geoffrey Dusheiko
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

4.  Occult infection related hepatitis B surface antigen variants showing lowered secretion capacity.

Authors:  Hong Kim; Seoung-Ae Lee; You-Sub Won; HyunJoo Lee; Bum-Joon Kim
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

5.  Dual chronic hepatitis B virus and hepatitis C virus infection.

Authors:  Chun-Jen Liu; Pei-Jer Chen; Ding-Shinn Chen
Journal:  Hepatol Int       Date:  2009-08-08       Impact factor: 6.047

6.  Spontaneous viral clearance after 6-21 years of hepatitis B and C viruses coinfection in high HBV endemic area.

Authors:  Chun-Lei Fan; Lai Wei; Dong Jiang; Hong-Song Chen; Yan Gao; Ruo-Bing Li; Yu Wang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

7.  Antibody to hepatitis B core antigen as a screening test for occult hepatitis B virus infection in Egyptian chronic hepatitis C patients.

Authors:  Assem El-Sherif; Mohamed Abou-Shady; Hany Abou-Zeid; Ahmed Elwassief; Ashraf Elbahrawy; Yoshihide Ueda; Tsutomu Chiba; Abdel-Moneim Hosney
Journal:  J Gastroenterol       Date:  2009-03-07       Impact factor: 7.527

8.  Naturally occurring mutations in large surface genes related to occult infection of hepatitis B virus genotype C.

Authors:  Hong Kim; Seoung-Ae Lee; Dong-Won Kim; Sueng-Hyun Lee; Bum-Joon Kim
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

9.  Markers for hepatitis A, B and C in methadone maintained patients: an unexpectedly high co-infection with silent hepatitis B.

Authors:  Gavin Bart; Paola Piccolo; Linqi Zhang; Ira Jacobson; Robert A Schaefer; Mary Jeanne Kreek
Journal:  Addiction       Date:  2008-04       Impact factor: 6.526

10.  Impact of hepatitis B exposure on sustained virological response rates of highly viremic chronic hepatitis C patients.

Authors:  Ioannis S Elefsiniotis; Christos Pavlidis; Elena Vezali; Theodoros Mariolis-Sapsakos; Sotirios Koutsounas; George Saroglou
Journal:  Gastroenterol Res Pract       Date:  2009-04-15       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.